Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HCG and letrozole for spermogram improvement in obese men with idiopathic infertility
IRCT20100614004181N9Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2019
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in unexplained male infertility (UMI) comparing hCG monotherapy, letrozole monotherapy and hCG + letrozole combination (3 arms). Primary endpoint: Spermogram test. Started Oct 2019; status: completed.
02
Drugs
human chorionic gonadotropinletrozole
03
Conditions
unexplained male infertility (UMI)
Beyond the preview
Go deeper on IRCT20100614004181N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100614004181N9.